UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A randomised, double-blind, phase III study comparing SB2, an infliximab biosimilar, to the infliximab reference product Remicade in patients with moderate to severe rheumatoid arthritis despite methotrexate therapy

Annals of the rheumatic diseases, 2017-01, Vol.76 (1), p.58-64

2017

Volltextzugriff (PDF)

Subclinical toxicity of calcineurin inhibitors in repeated protocol biopsies: an independent risk factor for chronic kidney allograft damage

Transplant international, 2010-04, Vol.23 (4), p.364-373

2010

Volltextzugriff (PDF)

The Examination of a TPMT Gene Before Administration of Azathioprine in Rheumatology Practice and Identification of a Novel Variant p.W29R

Journal of clinical rheumatology, 2022-03, Vol.28 (2), p.e363-e367

2022

Volltextzugriff (PDF)

Safety, immunogenicity and efficacy after switching from reference infliximab to biosimilar SB2 compared with continuing reference infliximab and SB2 in patients with rheumatoid arthritis: results of a randomised, double-blind, phase III transition study

Annals of the rheumatic diseases, 2018-02, Vol.77 (2), p.234-240

2018

Volltextzugriff (PDF)

Comparing biosimilar SB2 with reference infliximab after 54 weeks of a double-blind trial: clinical, structural and safety results

Rheumatology (Oxford, England), 2017-10, Vol.56 (10), p.1771-1779

2017

Volltextzugriff (PDF)

VEXAS syndrome: a report of three cases

Clinical and experimental rheumatology, 2022-07

2022

Volltextzugriff (PDF)

Serum tenascin-C discriminates patients with active SLE from inactive patients and healthy controls and predicts the need to escalate immunosuppressive therapy: a cohort study

Arthritis research & therapy, 2015-11, Vol.17 (1), p.341-341, Article 341

2015

Volltextzugriff (PDF)

Does the renal expression of Toll-like receptors play a role in patients with IgA nephropathy?

Journal of nephrology, 2020-04, Vol.33 (2), p.307-316

2020

Volltextzugriff (PDF)

Antibodies Against Complement System in SLE and their Potential Diagnostic Utility

Current rheumatology reviews, 2009-02, Vol.5 (1), p.58-63

2009

Volltextzugriff (PDF)

Differential diagnosis of back pain

Vnitřní lékar̆stvĭ, 2022-10, Vol.68 (5), p.332-341

2022

Volltextzugriff (PDF)

Baricitinib in treating rheumatoid arthritis

Interní medicína pro praxi, 2018-12, Vol.20 (5), p.274-277

Ciferská, Hana

2018

Volltextzugriff (PDF)

The levels of sCD30 and of sCD40L in a group of patients with systemic lupus erythematodes and their diagnostic value

Clinical rheumatology, 2007-05, Vol.26 (5), p.723-728

2007

Volltextzugriff (PDF)

Complement System in SLE as a Target for Antibodies

Current rheumatology reviews, 2013-01, Vol.9 (1), p.34-44

2013

Volltextzugriff (PDF)

Tofacitinib in treating psoriatic arthritis

Dermatologie pro praxi, 2019-03, Vol.13 (1), p.45-48

2019

Volltextzugriff (PDF)

Merkel cell carcinoma of the gluteal region with ipsilateral metastasis into the pancreatic graft of a patient after combined kidney-pancreas transplantation

Onkologie, 2010-01, Vol.33 (10), p.520-9

2010

Volltextzugriff (PDF)

Secukinumab in treating psoriatic arthritis

Klinická farmakologie a farmacie, 2017-05, Vol.31 (1), p.31-36

2017

Volltextzugriff (PDF)

Renal parenchymal hypertension: relevant new aspects

Vnitřní lékar̆stvĭ, 2021-12, Vol.67 (8), p.479-484

2021

Volltextzugriff (PDF)

European School of Internal Medicine (ESIM) in Brighton

European journal of internal medicine, 2011, Vol.22 (3), p.238-240

2011

Volltextzugriff (PDF)

European School of Internal Medicine (ESIM) in Brighton: experiences and reflections

European journal of internal medicine, 2011-06, Vol.22 (3), p.238-240

2011

Volltextzugriff (PDF)

Renal parenchymal hypertension: relevant new aspects

Vnitřní lékar̆stvĭ, 2021, Vol.67 (8), p.479

2021

Volltextzugriff (PDF)

Symptomatic treatment of gouty arthritis

Klinická farmakologie a farmacie, 2016-09, Vol.30 (2), p.32-37

2016

Volltextzugriff (PDF)

The levels of sCD30 and of sCD40L in a group of patients with systemic lupus erythematodes and their diagnostic value

Clinical rheumatology, 2007-05, Vol.26 (5), p.852-852

2007

Volltextzugriff (PDF)

Metabolic Osteopathy in Late-Onset Celiac Disease

Gerontorheumatology, 2017, p.245-254

2017

Volltextzugriff (PDF)

1 – 23 von 23

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(13)

Publikationsform

Artikel
(22)
Buchkapitel
(1)

Sprache

Englisch
(22)
Tschechisch
(2)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(13)
Science & Technology
(13)
Humans
(11)
Rheumatology
(10)
Male
(8)
Female
(7)
Adult
(6)
Aged
(6)
Middle Aged
(6)
Adolescent
(3)
Antibodies
(3)
Antirheumatic Agents - Adverse Effects
(3)
Arthritis, Rheumatoid - Drug Therapy
(3)
Biosimilar Pharmaceuticals - Adverse Effects
(3)
Complement System
(3)
Double-Blind Method
(3)
Rheumatoid Arthritis
(3)
Severity Of Illness Index
(3)
Systemic Lupus Erythematosus
(3)
Treatment Outcome
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A randomised, double-blind, phase III study comparing SB2, an infliximab biosimilar, to the infliximab reference product Remicade in patients with moderate to severe rheumatoid arthritis despite methotrexate therapy

Subclinical toxicity of calcineurin inhibitors in repeated protocol biopsies: an independent risk factor for chronic kidney allograft damage

The Examination of a TPMT Gene Before Administration of Azathioprine in Rheumatology Practice and Identification of a Novel Variant p.W29R

Safety, immunogenicity and efficacy after switching from reference infliximab to biosimilar SB2 compared with continuing reference infliximab and SB2 in patients with rheumatoid arthritis: results of a randomised, double-blind, phase III transition study

Comparing biosimilar SB2 with reference infliximab after 54 weeks of a double-blind trial: clinical, structural and safety results

VEXAS syndrome: a report of three cases

Serum tenascin-C discriminates patients with active SLE from inactive patients and healthy controls and predicts the need to escalate immunosuppressive therapy: a cohort study

Does the renal expression of Toll-like receptors play a role in patients with IgA nephropathy?

Antibodies Against Complement System in SLE and their Potential Diagnostic Utility

Differential diagnosis of back pain

Baricitinib in treating rheumatoid arthritis

The levels of sCD30 and of sCD40L in a group of patients with systemic lupus erythematodes and their diagnostic value

Complement System in SLE as a Target for Antibodies

Tofacitinib in treating psoriatic arthritis

Merkel cell carcinoma of the gluteal region with ipsilateral metastasis into the pancreatic graft of a patient after combined kidney-pancreas transplantation

Secukinumab in treating psoriatic arthritis

Renal parenchymal hypertension: relevant new aspects

European School of Internal Medicine (ESIM) in Brighton

European School of Internal Medicine (ESIM) in Brighton: experiences and reflections

Renal parenchymal hypertension: relevant new aspects

Symptomatic treatment of gouty arthritis

The levels of sCD30 and of sCD40L in a group of patients with systemic lupus erythematodes and their diagnostic value

Metabolic Osteopathy in Late-Onset Celiac Disease

Suchergebnisse filtern